Jefferies Group’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Jefferies Group’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-25,000	Closed	-$328K	–	2664
2014 Q1	$328K	Hold	25,000	–	–	﹤0.01%	1489
2013 Q4	$402K	Buy	+25,000	New	+$398K	﹤0.01%	1238

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

Jefferies Group's OSIR Position: Q2 2019 in Review

Jefferies Group sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 68,678 shares — an estimated $1.3M sold.

Jefferies Group first reported a position in OSIR in Q3 2013 and held it in 5 quarters. The position peaked at $1.3M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

Jefferies Group reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Jefferies Group sold 68,678 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $1.3M.
Jefferies Group first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2013 and held it in 5 quarters.
Jefferies Group's Osiris Therapeutics, Inc. Common Stock position peaked at $1.3M in Q1 2019.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Jefferies Group's 13F filing for Q2 2019, filed 14 Aug 2019.